Thakkar R, Rangraze IR, Gabhale SD, Ram J, Devarapalli N, Kudagi VS, Tiwari R. Correlation of ABO Blood Group Susceptibility to Disease Severity of SARS-COV-2: An Original Research.
J Pharm Bioallied Sci 2024;
16:S372-S375. [PMID:
38595378 PMCID:
PMC11000950 DOI:
10.4103/jpbs.jpbs_595_23]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2023] [Revised: 08/16/2023] [Accepted: 08/20/2023] [Indexed: 04/11/2024] Open
Abstract
COVID-19, the Ecumenical Pandemic that hit Wuhan, Hubei Province, China, in 2019 has instigated an emergency situation all over the globe. Current scientific corroborations highlighted the role of zoonotic cross-over species transmission for the spread of the deadly virus SARSCoV2. The proposition of ABO blood grouping to susceptibility for various infectious diseases has been documented in the past since blood group antigens constitute polymorphic traits that are inherited among humans, therefore are frequent targets in epidemiological studies.
Aim
To correlate the ABO blood group susceptibility to disease severity in COVID-19-positive cases among Indian populations.
Objectives
Association of ABO blood group patterns to disease severity in COVID-19-positive cases.
Materials and Methods
A cross-sectional, observational study design was conducted among 700 confirmed COVID-19-positive cases admitted to the tertiary health care center in Maharashtra, India. The data collected were subjected to statistical analysis.
Results
Blood group 'A' positive was frequent (40%) in severe COVID-19 (E group) disease, and 'O' positive blood group was frequent in moderate COVID-19 disease (34.62%).
Conclusion
ABO Blood grouping can be used as one of the efficient biomarker for COVID-19, thereby providing a new platform for therapeutic applications in the field of research.
Collapse